Dianthus Therapeutics Inc (DNTH)

Stock-Based Compensation

$11.90M

Quarterly · Period ending: · USD

DNTH logo

DNTH Stock-Based Compensation

Latest reported$11.90M
DNTH Quarterly Stock-Based Comp ($314.00K → $11.90M)
High-resolution chart · PNG

DNTH stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Dianthus Therapeutics Inc Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
11,898,000
10,602,000
5,978,000
5,794,000
5,706,000
5,315,000
3,918,000
3,840,000
3,101,000
2,035,000
726,000
1,179,000
462,000
533,000
513,000
0
0
0
0
0
0
2,192,000
2,331,000
2,366,000
2,504,000
2,740,000
2,062,000
2,762,000
2,600,000
2,577,000
2,551,000
3,676,000
3,051,000
1,425,000
773,000
565,000
607,000
314,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.